Accelerate process development with at-line concentration measurement
Feb
1
2022
On demand

Accelerate process development with at-line concentration measurement

Tuesday 08:00 PST / 11:00 EST / 16:00 GMT / 17:00 CET
Sponsor
Accelerate process development with at-line concentration measurement

Currently, the most commonly used methods for adeno-associated viral (AAV) vector quantitative analysis are qPCR and ELISA assays, along with analytical ultracentrifugation (AUC) and transmission electron microscopy (TEM). However, the time to results when using these methods can range from days to several weeks, and the acceptable tolerance range is high. Rapid, reliable in-process testing offers a significant benefit to AAV downstream process development, and can be achieved with Slope Spectroscopy utilizing Variable Pathlength Technology (VPT).

In this webinar, we will demonstrate how the CTech SoloVPE System, when used at-line in one or more stages of a process, can help to quickly identify process characteristics, provide key insights and allow for process optimization in minutes. VPT has enabled at-line measurement of concentration by eliminating the need for sample dilution or manipulation and delivering rapid and highly accurate real-time results.

  • Introduction to Slope Spectroscopy – a different method for UV-Vis concentration measurement
  • Review the Gene Therapy workflow for potential opportunities to accelerate testing to drive process efficiencies
  • Present gene therapy case studies demonstrating the CTech SoloVPE System performance

Joe Ferraiolo

Associate Director, Bioanalytics, Repligen

Joe leads the bioanalytics applications team and is in charge of the SoloVPE variable pathlength spectroscopy system for at-line applications. He has been with the company for more than 20 years, with over ten years of development and validation experience in analytical applications. He specializes in UV analysis and leads the development and commercialization of high-value products and flexible solutions that address critical steps in the production of biologics.

Joseph Ferraiolo
Joseph Ferraiolo
Associate Director, Bioanalytics at
Joe is the Associate Director Bioanalytics for Repligen. He is in charge of the Bioanalytics Applications department related to the SoloVPE Variable Pathlength UV solution. He has been with the company for more than 20 years, with over 10 years of development and validation experience in analytical applications. He specializes in UV analysis and leads the development and commercialization of high-value products and flexible solutions that address critical steps in the production of biologic drugs, gene therapy solutions, and monoclonal antibodies.

SPEAKERS

Joseph Ferraiolo
Joseph Ferraiolo
Associate Director, Bioanalytics at

You might also like

Same-section spatial multiomics: a platform for detailed analysis of the solid tumor TME

Same-section spatial multiomics: a platform for detailed analysis of the solid tumor TME

Emily Neil, Ariadna Pascual
27 June
in 70
Days
Register
Pure and simple: understanding LNP analytics for better mRNA-based drugs

Pure and simple: understanding LNP analytics for better mRNA-based drugs

Adam Crowe
29 May
in 41
Days
Register
Empowering patient care: in-process and quality control solutions for cellular therapies

Empowering patient care: in-process and quality control solutions for cellular therapies

Christin Tischner, Simon Lennartz
23 May
in 35
Days
Register
T cells from beginning to end: optimizing leukopak and drug product cryopreservation

T cells from beginning to end: optimizing leukopak and drug product cryopreservation

Meredith Safford, ShaNelle Yelity
22 May
in 34
Days
Register
Mastering AAV production: best practices For small- to large-scale manufacturing success and reduced development time

Mastering AAV production: best practices For small- to large-scale manufacturing success and reduced development time

Emily Jackson-Holmes
21 May
in 33
Days
Register